BioPharma Credit PLC
BOPCF
$0.93
Updated: 24/09/2026, 12:37:34
Market Cap
$1.04B
Sector
Financial Services
Industry
Asset Management
Country
GB
Stock valuation chart
One-year closing share-price history for BOPCF
Company Profile
Operating as an investment trust, BioPharma Credit PLC primarily allocates its capital to debt instruments that generate interest. The security for these investments is provided by royalties or other cash streams originating from the commercial sale of approved life sciences products. This company was established in 2016 and its headquarters are situated in Exeter, United Kingdom.
USD
OTC
CEO: Pedro Gonzalez de Cosio
Employees: 15
Asset Summaries
Latest generated summaries for BOPCF
No summaries found.
Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for BOPCF.
- Share price
- $0.93
- Market cap
- $1.04B
- Exchange
- OTC
- Currency
- USD
- CEO
- Pedro Gonzalez de Cosio
- Employees
- 15
- IPO date
- 21/08/2018
- Beta
- 0.101
- Last dividend
- $0.00
- Day range
- $0.93 – $0.93
- 52-week range
- $0.85 – $1.02
- 1-day performance
- -6.47%
- 1-year performance
- 8.93%
- Current drawdown (1Y)
- -9.20%
- CIK
- 0001702524
- CUSIP
- G12808104
- ISIN
- GB00BDGKMY29
- Created
- 07/12/2025, 03:04:41
- Last update
- 24/09/2026, 12:37:34
Track BioPharma Credit PLC with an AI analyst
See which prediction-market events move BOPCF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Latest Database News
News linked to BOPCF from your Railway `news_articles` table.
No news found for this symbol.